Literature DB >> 12419312

Identification of membrane-type receptor for bile acids (M-BAR).

Takaharu Maruyama1, Yasuhisa Miyamoto, Takao Nakamura, Yoshitaka Tamai, Hiromasa Okada, Eiji Sugiyama, Tatsuji Nakamura, Hiraku Itadani, Kenichi Tanaka.   

Abstract

Bile acids play an essential role in the solubilization and absorption of dietary fat and lipid-soluble vitamins. Bile acids also modulate the transcription of various genes for enzymes and transport proteins for their own and cholesterol homeostasis through binding to nuclear receptors. Here we report a novel category of bile acid receptor, a membrane-type G protein-coupled receptor (GPCR), BG37. Bile acids induced rapid and dose-dependent elevation of intracellular cAMP levels in BG37-expressing cells, but not in mock-transfected cells, independently of nuclear receptor expression. The rank order of potency of various bile acids for BG37-expressing cells was different from that for the nuclear receptor-mediated response. These observations demonstrate the presence of two independent signaling pathways for bile acids; membrane-type GPCR for rapid signaling and nuclear receptors for delayed signaling. Expression of BG37 was detected in various specific tissues, suggesting its physiological role, although it remains to be further characterized.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12419312     DOI: 10.1016/s0006-291x(02)02550-0

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  319 in total

1.  Metformin-induced glucagon-like peptide-1 secretion contributes to the actions of metformin in type 2 diabetes.

Authors:  Emilie Bahne; Emily W L Sun; Richard L Young; Morten Hansen; David P Sonne; Jakob S Hansen; Ulrich Rohde; Alice P Liou; Margaret L Jackson; Dayan de Fontgalland; Philippa Rabbitt; Paul Hollington; Luigi Sposato; Steven Due; David A Wattchow; Jens F Rehfeld; Jens J Holst; Damien J Keating; Tina Vilsbøll; Filip K Knop
Journal:  JCI Insight       Date:  2018-12-06

2.  Lowering bile acid pool size with a synthetic farnesoid X receptor (FXR) agonist induces obesity and diabetes through reduced energy expenditure.

Authors:  Mitsuhiro Watanabe; Yasushi Horai; Sander M Houten; Kohkichi Morimoto; Taichi Sugizaki; Eri Arita; Chikage Mataki; Hiroyuki Sato; Yusuke Tanigawara; Kristina Schoonjans; Hiroshi Itoh; Johan Auwerx
Journal:  J Biol Chem       Date:  2011-06-01       Impact factor: 5.157

3.  Conjugated bile acids activate the sphingosine-1-phosphate receptor 2 in primary rodent hepatocytes.

Authors:  Elaine Studer; Xiqiao Zhou; Renping Zhao; Yun Wang; Kazuaki Takabe; Masayuki Nagahashi; William M Pandak; Paul Dent; Sarah Spiegel; Ruihua Shi; Weiren Xu; Xuyuan Liu; Pat Bohdan; Luyong Zhang; Huiping Zhou; Phillip B Hylemon
Journal:  Hepatology       Date:  2011-11-30       Impact factor: 17.425

4.  Expression and function of the bile acid receptor GpBAR1 (TGR5) in the murine enteric nervous system.

Authors:  D P Poole; C Godfrey; F Cattaruzza; G S Cottrell; J G Kirkland; J C Pelayo; N W Bunnett; C U Corvera
Journal:  Neurogastroenterol Motil       Date:  2010-03-12       Impact factor: 3.598

Review 5.  Recent advances in gut nutrient chemosensing.

Authors:  C A Nguyen; Y Akiba; J D Kaunitz
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

Review 6.  Role of bile acids in the regulation of the metabolic pathways.

Authors:  Hiroki Taoka; Yoko Yokoyama; Kohkichi Morimoto; Naho Kitamura; Tatsuya Tanigaki; Yoko Takashina; Kazuo Tsubota; Mitsuhiro Watanabe
Journal:  World J Diabetes       Date:  2016-07-10

Review 7.  Bile acid-based therapies for non-alcoholic steatohepatitis and alcoholic liver disease.

Authors:  Tiangang Li; John Y L Chiang
Journal:  Hepatobiliary Surg Nutr       Date:  2020-04       Impact factor: 7.293

Review 8.  Bile acids: chemistry, physiology, and pathophysiology.

Authors:  Maria J Monte; Jose J G Marin; Alvaro Antelo; Jose Vazquez-Tato
Journal:  World J Gastroenterol       Date:  2009-02-21       Impact factor: 5.742

Review 9.  Fifty years of advances in bile acid synthesis and metabolism.

Authors:  David W Russell
Journal:  J Lipid Res       Date:  2008-09-24       Impact factor: 5.922

10.  Cerebrovascular dilation via selective targeting of the cholane steroid-recognition site in the BK channel β1-subunit by a novel nonsteroidal agent.

Authors:  Anna N Bukiya; Jacob E McMillan; Alexander L Fedinec; Shivaputra A Patil; Duane D Miller; Charles W Leffler; Abby L Parrill; Alex M Dopico
Journal:  Mol Pharmacol       Date:  2013-03-01       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.